What is the feedback from patients with platinib in the treatment of lung cancer?

Pralsetinib (Pralsetinib), developed by Blueprint Medicines, is a highly selective RET tyrosine kinase inhibitor mainly used to treat cancer patients carrying RET gene mutations. Platinib effectively blocks the growth and spread of tumor cells by inhibiting the activity of RET kinase, providing new treatment options for patients with various cancers such as lung cancer and medullary thyroid cancer. CStone Pharmaceuticals has obtained the exclusive development and commercialization authorization of this drug in Greater China, allowing more Chinese patients to benefit from this innovative therapy.

In the field of lung cancer treatment, platinib has shown significant clinical efficacy especially in patients with non-small cell lung cancer who are positive for metastatic rearrangement during transfection (RET) fusion. After receiving platinib treatment, many patients' conditions have been effectively controlled and their quality of life has been significantly improved.

In addition, the generic version of Platinib produced by Lucius Pharmaceuticals in Laos also provides patients with more choices. This generic drug is affordable, has been approved by the government, and its quality is guaranteed. Many patients have good feedback after use and the side effects are controllable.

Platinib is favored by patients not only because of its significant clinical efficacy, but also because of its relatively good tolerability. Many patients did not experience serious adverse reactions during the treatment and were able to complete the entire treatment cycle well. Of course, each patient's specific situation is different, and the treatment effects will also vary. But overall, platinib provides a new and effective treatment option for lung cancer patients.

In summary, platinib has demonstrated significant efficacy and good tolerability in the treatment of lung cancer, and has been widely praised by patients. Whether they are original drugs or generic drugs, they bring new hope and a better quality of life to patients.